Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Lars Fruergaard Jørgensen
CEOLars Fruergaard Jørgensen
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1931
Founded1931
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
354.70B
Market cap354.70B
Price-Earnings ratio
23.63
Price-Earnings ratio23.63
Dividend yield
1.48%
Dividend yield1.48%
Average volume
9.84M
Average volume9.84M
High today
$82.13
High today$82.13
Low today
$79.43
Low today$79.43
Open price
$81.41
Open price$81.41
Volume
7.49M
Volume7.49M
52 Week high
$148.15
52 Week high$148.15
52 Week low
$57.00
52 Week low$57.00

NVO News

Seeking Alpha 3d
Novo Nordisk taps Nvidia to accelerate drug discovery through AI

Nvidia (NASDAQ:NVDA) announced a collaboration with Novo Nordisk (NVO) (OTCPK:NONOF) on Wednesday to speed up the Danish pharma giant's efforts in drug discover...

Novo Nordisk taps Nvidia to accelerate drug discovery through AI
Sherwood News 5d
Obesity treatment startup Metsera rises on positive trial results

Obesity treatment startup Metsera rises on positive trial results New York-based obesity treatment startup Metsera is up by double digits after it reported enc...

Obesity treatment startup Metsera rises on positive trial results

Analyst ratings

60%

of 30 ratings
Buy
60%
Hold
30%
Sell
10%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.